Adil Koyuncu

Adil Koyuncu

Auto-generated profile, based on publicly available information

Adil Koyuncu

Univ Hlth Sci Turkey, Haseki Training & Res Hosp, Clin Gen Surg, Istanbul, Turkiye

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 November 2022 in Advances in Clinical and Experimental Medicine
Verified
Journal Article
Open access
AFAyse Gul Ferlengez
Ayse Gul Ferlengez
CTCihad Tatar
Cihad Tatar
MDMahmut Said Degerli
Mahmut Said Degerli
AKAdil Koyuncu
Adil Koyuncu
FAFatih Alper Ahlatci
Fatih Alper Ahlatci
UIUfuk Oguz Idiz
Ufuk Oguz Idiz
Acute pancreatitis (AP) is a disease that can still be fatal despite rapid advances in medicine. The relationship between serum nesfatin-1 levels and AP is still to be fully resolved. To investigate the utility of serum nesfatin-1 levels in the diagnosis of AP. Twenty-four male Sprague Dawley rats were divided into control, mild pancreatitis and severe pancreatitis groups (n = 8/group). Acute pancreatitis was induced by cerulein injection and the control group received saline injections. Then, the serum nesfatin-1, amylase, lipase, aspartate aminotransferase (AST), and alanine aminotransferase (ALT) levels were determined. A pathologist blinded to the study scored the severity of pancreatitis. There was a considerable decrease in serum nesfatin-1 levels in parallel to the severity of pancreatitis, though there was no statistically significant relationship observed between pancreatitis and nesfatin-1. In addition, there was no significant difference in AST or ALT levels among the groups. However, a strong positive correlation between amylase and lipase levels was observed (p < 0.05). The severe pancreatitis group (group 3) had a higher lipase level and pathology score than mild pancreatitis group (group 2), and this difference was statistically significant. Serum nesfatin-1 may be used as a diagnostic and severity marker in pancreatitis in the future.

1 February 2023 in Istanbul Medical Journal
Verified
Journal Article
Closed access
AKAdil Koyuncu
Adil Koyuncu
OAOmer Akay
Omer Akay
HSHusnu Ozan Sevik
Husnu Ozan Sevik
MGMert Guler
Mert Guler
SÖSena Cağla Özden
Sena Cağla Özden
CTCihad Tatar
Cihad Tatar

1 November 2021 in Medical Bulletin of Haseki
Verified
Journal Article
Closed access
MAMuzaffer Akinci
Muzaffer Akinci
AKAhmet Kocakusak
Ahmet Kocakusak
AHAdnan Hut
Adnan Hut
AKAdil Koyuncu
Adil Koyuncu
OAOkan Murat Akturk
Okan Murat Akturk
DYDogan Yildirim
Dogan Yildirim

27 June 2022 in Medical Bulletin of Haseki
Verified
Journal Article
Closed access
AKAdil Koyuncu
Adil Koyuncu
MDMahmut Said Degerli
Mahmut Said Degerli
SOSena Cagla Ozden
Sena Cagla Ozden
HGHUDA UMIT GUR
HUDA UMIT GUR
FEFazilet Erozgen
Fazilet Erozgen

5 March 2023 in Journal of Bionic Memory
Verified
Journal Article
Closed access
AKAdil Koyuncu
Adil Koyuncu
SOSongul Peltek Ozer
Songul Peltek Ozer
BOBahri Ozer
Bahri Ozer
OCOguz Catal
Oguz Catal
MSMustafa Sit
Mustafa Sit